Spinal muscular atrophy

Results: 193



#Item
41Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1  This study is a phase I, single-site, dose escalation study to evaluate the safety and efficacy of gene transfer for Spinal Muscular Atrophy Type 1 (SMA1).

Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 This study is a phase I, single-site, dose escalation study to evaluate the safety and efficacy of gene transfer for Spinal Muscular Atrophy Type 1 (SMA1).

Add to Reading List

Source URL: www.csma.org.ua

Language: English - Date: 2014-05-01 04:18:01
42http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-newsArtic

http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-newsArtic

Add to Reading List

Source URL: www.csma.org.ua

Language: English - Date: 2014-05-01 04:31:11
43Laboratory fish as models for embryonic development and disease Christoph Winkler, Department of Biological Sciences Assoc Prof Christoph Winkler Assoc Prof Christoph Winkler

Laboratory fish as models for embryonic development and disease Christoph Winkler, Department of Biological Sciences Assoc Prof Christoph Winkler Assoc Prof Christoph Winkler

Add to Reading List

Source URL: www.dbs.nus.edu.sg

Language: English - Date: 2010-01-20 01:39:08
44PUBLICATIONS  Исследования по прогнозу и развитию СМА.  all Related articles   1 . Function Changes in Spinal Muscular Atrophy II and III   By: B.S. Russman, MD; C.R. Buncher, ScD; M.

PUBLICATIONS Исследования по прогнозу и развитию СМА.  all Related articles   1 . Function Changes in Spinal Muscular Atrophy II and III   By: B.S. Russman, MD; C.R. Buncher, ScD; M.

Add to Reading List

Source URL: www.csma.org.ua

Language: English - Date: 2010-04-06 01:53:38
451  ANN Newsletter - No. 5 / October 2011 C li ni ca l T r i al s: UPD ATE Exon Skipping

1 ANN Newsletter - No. 5 / October 2011 C li ni ca l T r i al s: UPD ATE Exon Skipping

Add to Reading List

Source URL: www.ann.org.au

Language: English - Date: 2011-10-13 05:16:20
46Microsoft PowerPoint - CDDIS[removed]T-f01 [Compatibility Mode]

Microsoft PowerPoint - CDDIS[removed]T-f01 [Compatibility Mode]

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-06-20 09:56:28
47Cystic Fibrosis Carrier Screening  A/Prof David Amor, Director, Victorian Clinical Genetics Services and Dr Liane Ioannou, Honorary Research Officer, Murdoch Childrens Research Institute

Cystic Fibrosis Carrier Screening A/Prof David Amor, Director, Victorian Clinical Genetics Services and Dr Liane Ioannou, Honorary Research Officer, Murdoch Childrens Research Institute

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2014-08-04 22:23:00
48Australian NMD Registry Consent Form Version[removed]

Australian NMD Registry Consent Form Version[removed]

Add to Reading List

Source URL: nmdregistry.com.au

Language: English - Date: 2015-02-25 01:48:12
49Presidents Report As I reflect on my last 12 months as president of SMA-SA, I am able to see that the strengths of our organisation will ensure that it will continue to flourish well into the future. Council Members

Presidents Report As I reflect on my last 12 months as president of SMA-SA, I am able to see that the strengths of our organisation will ensure that it will continue to flourish well into the future. Council Members

Add to Reading List

Source URL: www.smasa.asn.au

Language: English - Date: 2012-12-06 01:09:12
50Australian NMD Registry Consent Form Version[removed]

Australian NMD Registry Consent Form Version[removed]

Add to Reading List

Source URL: nmdregistry.com.au

Language: English - Date: 2015-02-25 01:48:04